Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis.

New in this edition:¿ Drugs for ADHD thoroughly revised and updated¿ Antipsychotics with many changes and additions, including fully revised lab tests/monitoring¿ Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations¿ Hypnotics completely revised¿ Mood stabilizers fully revised and a new toxicity comparison table added¿ Drugs of abuse and treatment of substance use disorder comprehensively revised¿ New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use, and irritability of autism¿ New agents include: brexpiprazole, cariprazine, hypnotic suvorexant, tasimelteon, vortioxetine¿ New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Som-Pam, Tegretol (liquid), Trintellix, Versacolz, Vraylar, Vyvanse, Zelapar, ZenzediThe Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.¿ Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions¿) for a quick overview of treatment options¿ Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more - all you need to know for each class of drug¿ Potential interactions and side effects summarized in comparison charts¿ With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek¿ Clearly written patient and caregiver information sheets for download as printable PDF filesThis book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

Handbook of Clinical Psychopharmacology for Therapists has become the go-to resource for mental health clinicians looking for clear, reliable information about the treatment of mental health issues. Organized by disorder and, within each disorder, by medication, this book is designed to familiarize clinicians and students with the basic terminology and models of pharmacokinetics. This updated seventh edition provides essential information on new medications and treatment options and includes the latest research on side effects, contraindications, and efficacy of all major medications prescribed for mental health disorders. The book also features an important new chapter on the effects of withdrawing from psychopharmacological medications. This handbook makes it simple to: Get the facts about drug interactions and side effects Find out how medications affect adults, children, and adolescents differently Learn how different cultures view medical treatment, vital information for anyone who treats clients from a variety of backgrounds Discontinue medication safely when needed

"This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales."--page xx.

Our remedies are only as good as the way in which we dispense them. That is the central premise of Thinking About Prescribing. In this new, thought-provoking volume, more than two dozen experts make the case for an ongoing alliance between pharmacotherapists, young patients, and their families. Chapters tackle issues ranging from the psychodynamics of medication use in youth with serious mental illness, adapting evidence-based motivation and therapy techniques to enhance adherence, cultivating the synergistic role of primary care providers and psychotherapists, engaging in psychoeducation with patients, to prescribing via telemedicine. Readers will pick up the foundational knowledge they need to develop a partnership with patients that is based on trust and candid communication--rather than on just the cold facts about psychotropic medications. Chapters feature key takeaways that distill the most salient points, helping readers to reference--and retain--the information easily.

Poverty, substandard medical care, social neglect or withdrawal, unhealthy lifestyle -- these are just some of the contributors to the substantial morbidity of patients with severe mental illness. Medical deteriorations are often unexpected and severe, and particularly difficult to evaluate in the context of psychotic disorders. For this new edition, the Handbook of Medicine in Psychiatry has been updated and streamlined to provide a realistic approach to the medical issues encountered in psychiatric practice by helping clinicians answer whether their patient: Is at risk of dying or becoming severely disabled. Requires an immediate therapeutic intervention for a potentially life-threatening condition. Needs to be transferred to an emergency medicine setting. Requires urgent investigations. Must have changes made in the current medication regimen. Clinical vignettes for each chapter illustrate the complexity of the presentation of abnormal vital signs and somatic disorders in psychiatric settings, including fever, hypertension, seizures, and nausea and vomiting. The guide also provides risk stratification for major complications -- from abnormal thyroid function and acute kidney injury to myocarditis and venous thromboembolism -- enabling readers to determine the need for a transfer of the patient to an emergency medicine setting. A brand-new section features thorough discussions of topics requiring interdisciplinary collaboration with geriatricians, neurologists, anesthesiologists, addiction medicine, and adolescent medicine specialists. Clinicians working in today's busy inpatient and outpatient psychiatric settings will find in these pages a cognitive framework and knowledge base that will aid them in accurate decision making in the conditions of uncertainty created by potentially major medical deteriorations of the vulnerable populations under their care.

Clinicians recognize that monitoring psychotropic levels provides invaluable information to optimize therapy and track treatment adherence, but they lack formal training specifically focused on the use of plasma antipsychotic levels for these purposes. As new technologies emerge to rapidly provide these results, the opportunity to integrate this information into clinical care will grow. This practical handbook clarifies confusing concepts in the literature on use of antipsychotic levels, providing clear explanations for the logic underlying clinically relevant concepts such as the therapeutic threshold and the point of futility, and how these apply to individual antipsychotics. It offers accessible information on the expected correlation between dosages and trough levels, and also provides a clear explanation of how to use antipsychotic levels for monitoring oral antipsychotic adherence, and methods to help clinicians differentiate between poor adherence and variations in drug metabolism. An essential resource for psychiatrists, psychiatric nurse practitioners, and mental health professionals worldwide.